• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织学与乳腺癌预后

Histology in breast cancer prognosis.

作者信息

Champion H R, Wallace I W, Prescott R J

出版信息

Br J Cancer. 1972 Apr;26(2):129-38. doi: 10.1038/bjc.1972.19.

DOI:10.1038/bjc.1972.19
PMID:4114100
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2008433/
Abstract

Histological sections of the primary tumour and of homolateral axillary lymph nodes from 500 women with operable invasive breast cancer have been examined. The tumours have been graded and the degree of round cell infiltration assessed. These features, together with clinical palpability and pathological involvement of axillary nodes, have been related to survival.It was found that prognosis was worse in patients with a high grade tumour and in those with histological evidence of axillary node spread. Round cell infiltration of the primary tumour did not confer improved survival.The clinical state of the axillary nodes was associated with prognosis in so far that palpable nodes were twice as commonly the seat of metastatic spread as were impalpable nodes.

摘要

对500例可手术切除的浸润性乳腺癌女性患者的原发肿瘤及同侧腋窝淋巴结进行了组织学切片检查。对肿瘤进行了分级,并评估了圆形细胞浸润程度。这些特征,连同腋窝淋巴结的临床可触及性和病理累及情况,均与生存率相关。结果发现,高级别肿瘤患者以及有腋窝淋巴结转移组织学证据的患者预后较差。原发肿瘤的圆形细胞浸润并未带来生存率的提高。腋窝淋巴结的临床状态与预后相关,因为可触及的淋巴结发生转移扩散的几率是不可触及淋巴结的两倍。

相似文献

1
Histology in breast cancer prognosis.组织学与乳腺癌预后
Br J Cancer. 1972 Apr;26(2):129-38. doi: 10.1038/bjc.1972.19.
2
Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases.乳腺癌女性前哨淋巴结出现转移时,对其余腋窝淋巴结肿瘤累及情况的预测
Br J Surg. 2003 Nov;90(11):1354-60. doi: 10.1002/bjs.4325.
3
Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.前哨淋巴结活检以避免对临床腋窝淋巴结阴性的乳腺癌患者进行腋窝清扫术。
Lancet. 1997 Jun 28;349(9069):1864-7. doi: 10.1016/S0140-6736(97)01004-0.
4
Axillary lymph node metastases in patients with small carcinomas of the breast: is accurate prediction possible?小乳腺癌患者腋窝淋巴结转移:能否进行准确预测?
Eur J Surg. 2000 Aug;166(8):610-5. doi: 10.1080/110241500750008259.
5
[Lobular invasive breast cancer prognostic factors: About 940 patients].小叶浸润性乳腺癌的预后因素:约940例患者
Gynecol Obstet Fertil. 2015 Nov;43(11):712-7. doi: 10.1016/j.gyobfe.2015.09.007. Epub 2015 Oct 16.
6
Correlation Between Raf/MEK/ERK Signaling Pathway and Clinicopathological Features and Prognosis for Patients With Breast Cancer Having Axillary Lymph Node Metastasis.Raf/MEK/ERK信号通路与腋窝淋巴结转移乳腺癌患者临床病理特征及预后的相关性
Technol Cancer Res Treat. 2018 Jan 1;17:1533034617754024. doi: 10.1177/1533034617754024.
7
Subareolar injection of technetium-99m nanocolloid yields reliable data on the axillary lymph node tumour status in breast cancer patients with previous manipulations on the primary tumour: a prospective study of 117 patients.乳晕下注射99m锝纳米胶体可为先前对原发性肿瘤进行过处理的乳腺癌患者腋窝淋巴结肿瘤状态提供可靠数据:一项针对117例患者的前瞻性研究。
Eur J Nucl Med Mol Imaging. 2004 May;31(5):671-5. doi: 10.1007/s00259-003-1447-z. Epub 2004 Jan 27.
8
[Axillary node removal in clinical node-negative breast carcinoma. Can its indication be individualized by "sentinel node" detection?].
Dtsch Med Wochenschr. 1998 May 8;123(19):583-7. doi: 10.1055/s-2007-1024023.
9
Mean nuclear area and histological grade of axillary-node tumour in breast cancer, related to prognosis.乳腺癌腋窝淋巴结肿瘤的平均核面积和组织学分级与预后的关系。
Br J Cancer. 1982 Jul;46(1):95-100. doi: 10.1038/bjc.1982.170.
10
Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.腋窝淋巴结转移阳性率可预测非转移性乳腺癌患者的生存率。
Acta Oncol. 2008;47(2):232-8. doi: 10.1080/02841860701678761.

引用本文的文献

1
Core biopsy as a tool in planning the management of invasive breast cancer.核心活检作为规划浸润性乳腺癌治疗方案的一种工具。
World J Surg Oncol. 2005 Jan 4;3(1):1. doi: 10.1186/1477-7819-3-1.
2
EBAG9/RCAS1 in human breast carcinoma: a possible factor in endocrine-immune interactions.人乳腺癌中的EBAG9/RCAS1:内分泌-免疫相互作用的一个可能因素。
Br J Cancer. 2001 Nov 30;85(11):1731-7. doi: 10.1054/bjoc.2001.2176.
3
The possible role of stromal cell stimulation in worsening the prognosis of a subset of patients with breast cancer.基质细胞刺激在恶化一部分乳腺癌患者预后方面的潜在作用。
Clin Exp Metastasis. 1993 Jul;11(4):295-305. doi: 10.1007/BF00058049.
4
Predictors of recurrence in stage I (T1N0M0) breast carcinoma.I期(T1N0M0)乳腺癌复发的预测因素。
Ann Surg. 1981 Jan;193(1):15-25. doi: 10.1097/00000658-198101000-00003.
5
Mononuclear stromal reactions in mammary carcinoma, with special reference to medullary carcinomas with a lymphoid infiltrate. Analysis of 108 cases.乳腺癌中的单核基质反应,特别提及伴有淋巴细胞浸润的髓样癌。108例分析。
Virchows Arch A Pathol Anat Histol. 1981;393(1):75-91. doi: 10.1007/BF00430872.
6
The cancer research campaign (King's/Cambridge trial for early breast cancer: clinico-pathological aspects.癌症研究运动(国王学院/剑桥早期乳腺癌试验:临床病理方面)
Br J Cancer. 1982 May;45(5):655-69. doi: 10.1038/bjc.1982.106.
7
Percentage malignant involvement: a new concept in staging of breast cancer.恶性累及百分比:乳腺癌分期中的一个新概念。
Ann R Coll Surg Engl. 1983 Jan;65(1):11-3.
8
Prognosis in stage II (T1N1M0) breast cancer.II期(T1N1M0)乳腺癌的预后
Ann Surg. 1981 Nov;194(5):576-84. doi: 10.1097/00000658-198111000-00005.
9
Local immunoglobulin production in breast cancer.乳腺癌中的局部免疫球蛋白产生
Br J Cancer. 1973 Apr;27(4):269-75. doi: 10.1038/bjc.1973.33.
10
Lymphoreticular infiltration in human tumours: prognostic and biological implications: a review.人类肿瘤中的淋巴网状浸润:预后及生物学意义:综述
Br J Cancer. 1974 Dec;30(6):538-48. doi: 10.1038/bjc.1974.233.

本文引用的文献

1
LONGEVITY IN CANCER: A STUDY OF 293 CASES.癌症患者的长寿情况:293例病例研究。
Ann Surg. 1922 Jul;76(1):9-12.
2
Survival in breast cancer cases in relation to the structure of the primary tumor and regional lymph nodes.乳腺癌病例的生存情况与原发肿瘤及区域淋巴结结构的关系。
Surg Gynecol Obstet. 1955 May;100(5):543-51.
3
Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years.乳腺癌的组织学分级与预后;对1409例病例的研究,其中359例已随访15年。
Br J Cancer. 1957 Sep;11(3):359-77. doi: 10.1038/bjc.1957.43.
4
Medullary carcinoma of the breast; a distinctive tumour type with a relatively good prognosis following radical mastectomy.乳腺髓样癌;一种独特的肿瘤类型,根治性乳房切除术后预后相对较好。
Br J Cancer. 1956 Sep;10(3):415-23. doi: 10.1038/bjc.1956.48.
5
Lymph node structure in patients with cancer of the breast.乳腺癌患者的淋巴结结构
Am J Pathol. 1953 May-Jun;29(3):505-21.
6
Histological grading in breast cancer.乳腺癌的组织学分级
Br J Cancer. 1969 Jun;23(2):294-301. doi: 10.1038/bjc.1969.39.
7
Possible host resistance in carcinoma of the breast: a histological study.乳腺癌中可能存在的宿主抵抗力:一项组织学研究。
Br J Cancer. 1968 Sep;22(3):383-401. doi: 10.1038/bjc.1968.47.
8
Host resistance and survival in carcinoma of breast: a study of 104 cases of medullary carcinoma in a series of 1,411 cases of breast cancer followed for 20 years.乳腺癌患者的宿主抵抗力与生存率:对1411例乳腺癌患者中的104例髓样癌患者进行了为期20年的随访研究。
Br Med J. 1970 Jul 25;3(5716):181-8. doi: 10.1136/bmj.3.5716.181.
9
Treatment of early mammary carcinoma: a cooperative international study.早期乳腺癌的治疗:一项国际合作研究。
Ann Surg. 1969 Dec;170(6):875-8. doi: 10.1097/00000658-196912000-00001.
10
Breast cancer grading.乳腺癌分级
Br J Cancer. 1971 Sep;25(3):441-8. doi: 10.1038/bjc.1971.56.